This breaks down to approximately: 1.7mg GHK-Cu 0.33mg BPC-157 0.33mg TB-500 Use a 0.3ml (30-unit) insulin syringe for greater measurement precision at these low volumes
View Study [4]"Activation of the GH/IGF-1 axis by CJC-1295 results in serum protein profile changes in normal adult subjects" Sackmann-Sala L, Ding J, Frohman LA et al., 2009 Finding: CJC-1295 administration caused measurable changes in serum protein profiles, indicating activation of the GH/IGF-1 axis with potential biomarkers of GH activity
Documented benefits include improved insulin sensitivity in type 2 diabetes (20), reduced inflammatory cytokines and short-term mortality in sepsis (21), and ameliorated cardiac fibrosis in experimental heart failure models (22)
doi: 10.1093/gerona/58.11.b970 34 CrucianiRDvorkinEHomelPMalamudSCullineyBLapinJet al
GH Receptor Independence: Critical verification that effects are GH receptor-independent: No IGF-1 elevation No effects on linear growth Activity in GH receptor knockout models No displacement of hGH from its receptor Compliance and Safety Information Regulatory Status: AOD9604 is provided as a research chemical for in-vitro laboratory studies and preclinical research only